Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1068 results for "pharma trading company"

Aurobindo Pharma receives USFDA approval for Lacosamide Tablets
India Infoline

Aurobindo Pharma trades with traction on the bourses

SENSEX 25290.40 146.57 0.58% NIFTY 7762.05 43.85 0.56% Industry: Medical/Healthcare Company Aurobindo Pharma Ltd Aurobindo Pharma is currently trading at Rs. 801.50, up by 31.80 points or 4.13 % from its previous closing of ..., 35 minutes ago

Alembic Pharma tumbles 2% despite FDA go-ahead for partialĀ­ onset seizures drug

Shares of Alembic Pharma closed 1.59% lower at Rs. 593.30 on BSE after the company received USFDA's approval for partialĀ­ onset seizures drug. The company has received final approval from the US Food & Drug Administration (USFDA) for its ...
 India Infoline22 hours ago Marksans Pharma shines on receiving USFDA approval for Metformin Hydrochloride ER Tablets  Finalaya.com1 day ago Alembic Pharma gets USFDA nod for seizures treatment drug  DNA1 day ago Marksans gets USFDA approval and other top pharma news  India Infoline3 hours ago
India Infoline

Glenmark Pharma surges 1% on FDA nod

Shares of Glenmark Pharma are currently trading 1.47% higher at Rs. 830.50 on BSE after its parent company Glenmark Pharmaceuticals Inc., USA (Glenmark) granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for ...
 India Infoline4 days ago Glenmark Pharma gains after receiving tentative approval from USFDA for drug  Capital Market4 days ago Glenmark Pharma gains 2%  India Infoline1 week ago
India Infoline

Dishman Pharma gains on fixing record date for bonus

Email this Print Dishman Pharmaceuticals & Chemicals was trading higher by 4% to Rs 356 on the BSE after the company fixed May 03, 2016 as the record date for the bonus shares in the ratio of 1:1. The management committee of board of directors ...
 Smart Investor1 week ago Dishman Pharma rallies 4%; gets nod for bonus issue  India Infoline1 week ago Dishman Pharma receives Shareholders nod for Bonus Share issue  India Infoline1 week ago Dishman Pharma climbs 3% on fixing record date for bonus issue  Economic Times1 week ago

Horizon Pharma PLC (HZNP) Shares Down 3.4% on Analyst Downgrade

Horizon Pharma PLC (NASDAQ:HZNP) shares dropped 3.4% during mid-day trading on Tuesday after Citigroup lowered their price target on the stock from $21.00 to $18.00, Analyst Ratings Net reports. Citigroup currently has a neutral rating on the stock.
 American Banking News - Forex6 days ago Citigroup Inc. Trims Horizon Pharma PLC (HZNP) Target Price to $18.00  Ticker Report4 days ago Horizon Pharma PLC (HZNP) Stake Boosted by Millennium Management LLC  WKRB News3 hours ago HORIZON PHARMA PLC : (HZNP), Ciena Corporation (CIEN)  4 Traders1 week ago
Ticker Report

Cerulean Pharma Inc (CERU) Stock Price Down 9%

Cerulean Pharma Inc (NASDAQ:CERU) traded down 9% during trading on Friday , Market reports. The company traded as low as $3.21 and last traded at $3.23, with a volume of 205,293 shares trading hands. The stock had previously closed at ...
 Ticker Report2 days ago EPS Decline Expected for Flex Pharma Inc (FLKS)  Octafinance5 hours ago Analysis and Cerulean Pharma Inc (CERU) Earnings Review  Octafinance9 hours ago Flex Pharma Inc (FLKS) Earns Buy Rating from Jefferies Group  WKRB News1 week ago
American Banking News - Forex

Evoke Pharma Inc (EVOK) Trading Up 1.9%

Evoke Pharma Inc (NASDAQ:EVOK) was up 1.9% on Tuesday , Market Beat Ratings reports. The company traded as high as $5.55 and last traded at $5.30, with a volume of 107,756 shares trading hands. The stock had previously closed at $5.20. A number of ...
 Ticker Report1 week ago IntelliPharmaCeutics Intl Inc (IPCI) Shares Up 4.3%  Ticker Report1 week ago Parters Vii L. P. Domain Sells 5,095 Shares of Evoke Pharma Inc (EVOK) Stock  American Banking News - Forex5 days ago Evoke Pharma Inc (EVOK) Major Shareholder Sells $221,907.30 in Stock  Ticker Report1 week ago
India Infoline

Ajanta Pharma Ltd 29 Apr 2016

Ajanta Pharma, specialty pharmaceutical company, reported consolidated net profit of Rs.106.31 crore for the quarter ended March 31, 2016, registering growth of 43.39% yoy, but decline of 4.48% qoq. The company's revenue stood at Rs. 425.73 crore, ...
 India Infoline1 day ago Ajanta Pharma Q4 Net Up 43% At Rs 106 Crore  NDTV3 days ago Ajanta Pharma Q4 net up 43 per cent at Rs 106 crore  Economic Times3 days ago
Financial Express

Aurobindo Pharma shares surge 5% on USFDA approval for epilepsydrug

More Aurobindo Pharma shares advanced over 5 per cent on Tuesday after the pharma company announced that it has received US Food & Drug Administration (USFDA) approval for its epilepsy prevention drug Lacosamide. At 12.22 pm, shares of Aurobindo ...
 Yahoo! India1 hour ago Marksans Pharma shares surge on USFDA nod for diabetes drugs  Financial Express1 day ago Marksans Pharma shares surge 10% on USFDA nod for diabetes drugs  Financial Express22 hours ago

Benchmark indices extend gains in late trade

Stocks of public sector banks, metal and mining firms and pharma companies led the rally for key benchmark indices. The barometer index, the S&P BSE Sensex, rose 327.92 points or 1.35% at 24,666.35, as per the provisional closing data. The ...
 Business Standard2 months ago Sensex Up Over 100 Points  Equitymaster.com1 month ago Pharma Stocks Lead the Losses  Equitymaster.com1 month ago Roller Coaster Ride! BSE Sensex, Nifty end in the green  India Infoline3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less